Citation

Gerlach KK, Dasgupta N, Schnoll SH, Henningfield JE. Neuropharmacology 2014; 87: 91-96.

Affiliation

PinneyAssociates, Inc. 4800 Montgomery Lane, Suite 400, Bethesda, MD 20814; The Johns Hopkins University, School of Medicine, Baltimore, MD 21229.

Copyright

(Copyright © 2014, Elsevier Publishing)

DOI

10.1016/j.neuropharm.2014.04.020

PMID

24813641

Abstract

Stimulants are a diverse array of drugs that range from everyday caffeine to prescription medications and illicitly manufactured street drugs. The surveillance of misuse and abuse of stimulants many times confounds prescription and illicit street drugs such that the data are not specific enough to guide mitigation efforts or assess their impact. This review highlights the surveillance efforts that are conducted in the United States (US) for stimulant misuse and abuse. These surveillance efforts include national level surveys as well as reporting systems such as Poison Centers and emergency departments. This epidemiologic analysis has implications for interpreting the current known neuropharmacology of stimulants and possibly informing future neuropharmacology research that may contribute to a better understanding of potential neuropharmacologic factors influencing differing patterns of use, abuse, and adverse consequences associated with various stimulants.

Language: en